Measuring our financial performance—Mater Research

Home > Part Three: Our performance > Measuring our financial performance—Mater Research
coming soon.
Revenue
Amount
Percentage
Grant income
$8 202 017
31%
UQ infrastructure funding
$2 771 913
11%
Commercial funding
$167 680
1%
Mater infrastructure funding
$2 000 000
8%
Donations and bequests
$11 185 377
43%
Other income
$1 931 925
7%
Total
$26 258 912
 
Expenditure
Amount
Percentage
Administration expenses
$3 763 537
14%
Research support expenses
$8 030 829
31%
Research and development expenses
$14 402 438
55%
Total
$26 196 803
 

Mater Research published 362 publications during the 2015/16 financial year, in both national and international health literature. Highlights of the year include Mater Research-led studies being published in Cell, Cell Research and The Lancet.  A full list of Mater Research publications (2015, and January to June 2016) can be accessed via the Mater Research website.


SHARE     
 
< Previous Page
Next Page >